IL33 and allergic disease: Finally, as a corollary parallel analysis showed that administration of rLc-IL12 suppressed allergic reaction without downregulating levels of IEC-derived IL-33 while at the same time partially suppressing allergy-associated expression of OX40L (Figure S4 in Supplementary Material).